跳至主要内容
临床试验/NCT02758210
NCT02758210已完成不适用

Evaluating the Electro Magnetic Interference of Using Tablet and Smart Phone on Leadless Pacemaker (MICRA)

Emory University2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2016年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Number of Participants Experiencing Inhibition of Ventricular Pacing While Using a Smart Phone

研究概览

简要总结

The purpose of this study is to evaluate the effects that electromagnetic field exposure from using a tablet and smart phone have on a leadless pacemaker (MICRA device).

详细描述

With advancement in technology, people are exposed to new sources of electromagnetic field like tablets and smart phones. There are magnets in smart phones and tablets that could affect the functions of pacemakers. The main purpose of this study is to evaluate the effects of electromagnetic field exposure from using a tablet and a smart phone with participants that have a leadless pacemaker (MICRA device) implanted inside them. Participants will be asked to report any symptoms that they experience during the testing.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Patients enrolled in MICRA Study and MICRA CA study at Emory University Hospital and Emory Midtown Hospital
  • •Able to consent

排除标准

  • •Patients not enrolled in MICRA Study and MICRA CA study at Emory University Hospital and Emory Midtown Hospital
  • •Children and vulnerable populations

研究组 & 干预措施

Participants with MICRA Device

Experimental

Participants that received the MICRA device prior to study enrollment will have monitored use of Smart Phone and Tablet at one study visit. Electrogram printing will take place during use of each device to see if there is any pacing inhibition or asynchronous pacing.

干预措施: Use of a Tablet (Device)

Participants with MICRA Device

Experimental

Participants that received the MICRA device prior to study enrollment will have monitored use of Smart Phone and Tablet at one study visit. Electrogram printing will take place during use of each device to see if there is any pacing inhibition or asynchronous pacing.

干预措施: Use of a Smart Phone (Device)

结局指标

主要结局

Number of Participants Experiencing Inhibition of Ventricular Pacing While Using a Smart Phone

时间窗: Baseline (Before use of Smart Phone), During use of Smart Phone (an average of 5 minutes)

Ventricular pacing before and during use of a smart phone was monitored to assess the presence of inhibition of ventricular pacing due to electromagnetic field exposure. The programmed pacing of the MICRA device is specific for each participant. The individualized, initial programmed pacing settings of the MICRA device are compared to any changes during the smart phone usage.

Number of Participants Experiencing Asynchronous Pacing While Using a Tablet

时间窗: Baseline (Before use of Tablet), During use of Tablet (an average of 5 minutes)

Cardiac pacing before and during use of a tablet were monitored to assess if there is asynchronous pacing due to electromagnetic field exposure. The initial programmed pacing settings of the MICRA device are compared to any changes during the tablet usage.

Device Response While Using a Tablet, Assessed by Ventricular Pacing

时间窗: Baseline (Before use of Tablet), During use of Tablet (an average of 5 minutes)

Ventricular pacing before and during use of a tablet was monitored to assess if there's inhibition of ventricular pacing due to electromagnetic field exposure. The initial programmed pacing settings of the MICRA device are compared to any changes during the tablet usage. The assessment of this outcome measure takes an average of 5 minutes.

Device Response Assessed by Asynchronous Pacing When Using a Smart Phone

时间窗: Baseline (Before use of Smart Phone), During use of Smart Phone (an average of 5 minutes)

Cardiac pacing before and during use of a smart phone was monitored to assess asynchronous pacing due to electromagnetic field exposure. The initial programmed pacing settings of the MICRA device are compared to any changes during the smart phone usage.

次要结局

  • Number of Participants Reporting Clinical Symptoms While Using a Tablet(Baseline (Before use of Tablet), During use of Tablet (an average of 5 minutes))
  • Number of Participants Reporting Clinical Symptoms While Using a Smart Phone(Baseline (Before use of Smart Phone), During use of Smart Phone (an average of 5 minutes))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mikhael El Chami

Associate Professor

Emory University

研究点 (2)

Loading locations...

相似试验